TWM622000U - Medical supplies tracking management system - Google Patents

Abstract

The pharmaceutical tracking management payment cash flow system includes a database, a message transmission/reception module and a management module. The message transmission/reception module is used to receive the label information, manufacturing and distribution history, inventory history and insurance payment process of pharmaceuticals, and transmit the manufacturing and distribution history, inventory history and insurance payment process to a blockchain Internet and Databases. The management module signal is connected to the message transmission/reception module and the database, and includes the history query module and the inventory and cash flow management module. The signal of the inventory and cash flow management module is connected to the history query module, and according to the label information, the inventory history and insurance cash flow payment history of the medicine corresponding to the identification label are obtained from the database.

Description

Pharmaceutical tracking management payment cash flow system

This new model relates to a pharmaceutical tracking management payment cash flow system, especially a pharmaceutical tracking management payment cash flow system that is convenient for users to view medical data on a blockchain network.

In the process of treating diseases and administering vaccines, various medicines are required. Ordinary pharmaceuticals are produced by pharmaceutical factories, then transported to hospitals by logistics agencies, and then administered to patients by hospital medical staff. At present, there is no system that can trace the production source, transportation logistics, use process and storage process (from the manufacturing end to the storage, and finally the process of being used by medical personnel) of pharmaceuticals. Existing payment systems are also unable to connect instantly, and respond instantly to payments and cash flows.

In addition, after the medicines are delivered to the hospital, the existing storage system of the hospital does not warn the hospital when the medicines are about to expire. Therefore, the hospitals often have to scrap the medicines after discovering that the medicines are expired, causing Waste of medical resources, or too much inventory results in a waste of funds.

Therefore, it is necessary to provide a pharmaceutical tracking management payment cash flow system, which can be used by any user in the production end, logistics end, user end and storage end of pharmaceutical products to trace the production source, transportation logistics, use history and storage of pharmaceutical products. Warehousing process to control the deterioration of drug or vaccine ingredients due to mistakes in production source, transportation logistics, use and storage process, and cause allergies or other adverse reactions in patients, and then clarify the responsibility lies with the manufacturer, logistics carrier, At the same time, it is necessary for hospitals or warehouses to provide a complete set of traceability, which can solve the problems existing in the existing technology by integrating the overall delivery information, injection information, patient information and insurance payment.

The main purpose of this new model is to provide a pharmaceutical tracking management payment cash flow system that is convenient for users to view medical data on the blockchain network.

In order to achieve the above-mentioned purpose, a new type of medical product tracking management payment flow system is used to receive one of the manufacturing, circulation and use history, an inventory history and an insurance cash flow payment history of a medicinal product transmitted by a third-party organization, and For a user to track the history of manufacturing, circulation and use, inventory history and an insurance cash flow payment history. The medicine includes an identification tag and the identification tag includes a tag information. The pharmaceutical tracking management payment cash flow system includes a database, a message transmission/reception module and a management module. The message transmission/reception module is used to receive the label information, manufacturing and distribution history, inventory history and insurance payment process of pharmaceuticals, and transmit the manufacturing and distribution history, inventory history and insurance payment process to a blockchain Internet and Databases. The management module signal is connected to the message transmission/reception module and the database, and includes the history query module and the inventory and cash flow management module. The history query module obtains the manufacturing, distribution and use history of the medicine corresponding to the identification label from the database according to the label information. The signal of the inventory and cash flow management module is connected to the history query module, and according to the label information, the inventory history and insurance cash flow payment history of the medicine corresponding to the identification label are obtained from the database.

According to an embodiment of the present invention, the third-party organization includes a manufacturer of pharmaceuticals, a logistics provider, a user terminal, a storage terminal, and an insurance payment terminal, and the manufacturing, distribution and use process includes a manufacturing process, a Circulation process and a use process. The message transmission/reception module respectively receives the manufacturing process, circulation process and usage process transmitted by the manufacturer, logistics provider and the user, and receives the inventory process transmitted by the warehouse and the insurance payment process transmitted by the insurance payment terminal. .

According to an embodiment of the present invention, the inventory history includes a manufacturing date, a use period, a purchase date, an inventory quantity, a shipping date, and a use date of the drug, and the insurance payment history includes a drug A benefit stream payment date and a benefit stream payment amount.

According to an embodiment of the present invention, the inventory and cash flow management module is further used to monitor whether the medicines are expired according to the inventory history.

According to an embodiment of the present invention, the inventory and cash flow management module is further configured to determine whether the medicine should be returned or transferred according to the inventory history.

According to an embodiment of the present invention, the user end includes a tag reader/writer, and the user obtains tag information through the tag reader/writer.

According to an embodiment of the present invention, the identification tag is a radio frequency tag or a near field communication tag, and the tag reader/writer is a radio frequency identification (RFID) reader or a near field communication (NFC) tag reader writer.

According to an embodiment of the present invention, the medicinal products include medicinal injections.

According to an embodiment of the present invention, the user terminal is a medical institution, and the usage process is the information of the hospital patient injection terminal.

In order to better understand the technical content of the present invention, preferred specific embodiments are given and described as follows.

Hereinafter, please refer to FIG. 1 to FIG. 3 together for the payment cash flow system for tracking and managing pharmaceuticals according to an embodiment of the present invention. Figure 1 is a system architecture diagram of a pharmaceutical tracking management payment cash flow system, a blockchain network, an external computer, a pharmaceutical factory computer, a logistics computer, a medical computer, a storage computer and an insurance cash flow payment computer according to an embodiment of the present invention ; Figure 2 is a three-dimensional exploded view of a medicine according to an embodiment of the present invention; Figure 3 is a schematic diagram of a medicine and a syringe according to an embodiment of the present invention.

In an embodiment of the present invention, as shown in FIG. 1 , the pharmaceutical tracking and management payment cash flow system 900 is used for any user in a third-party organization to track one of the manufacturing, distribution and use history of a pharmaceutical 1 , a Inventory process 214 and an insurance payment process 215 . The third-party organization includes a manufacturer, a logistics provider, a user terminal, a storage terminal and an insurance payment terminal. The manufacturing, distribution and use history includes a manufacturing history 211 , a circulation history 212 and a use history 213 . The manufacturer is a pharmaceutical company and manufactures the pharmaceutical product 1. The pharmaceutical company has a pharmaceutical computer 600, and the pharmaceutical computer 600 includes a pharmaceutical computer blockchain module 610 to connect the blockchain network 300 with a signal. The logistics provider is a logistics organization and transports the medicine 1 from the pharmaceutical factory to the hospital or pharmacy that needs the medicine 1. The logistics organization has a logistics computer 700, and the logistics computer 700 includes a logistics computer block chain module 710 and more. The signal is connected to the blockchain network 300 . The user terminal can be a medical terminal, such as a medical institution, that is, a hospital or a pharmacy that receives the medicine 1. The medical institution has a medical computer 800, and the medical computer 800 includes a medical computer blockchain module 810. and a tag reader/writer 820. The medical computer block chain module 810 is used to connect the block chain network 300 with a signal; however, the user end is not limited to the above, it can also be the treated end (for example, a patient), such as the use of medicines 1 patients, or the payer (such as an insurance company), or a third-party impartial end (such as a backup agency). The storage end is a refrigerated warehouse set up in a hospital or a pharmacy, which is used to store medicines 1 in a specific temperature environment. The storage end has a storage computer 500, and the storage computer 500 includes a storage computer blockchain module 510 to connect the blockchain network 300 with a signal. The insurance payment terminal has an insurance payment computer 1000, and the insurance payment computer 1000 includes an insurance payment blockchain module 1010 connected to the blockchain network 300 by a signal.

In an embodiment of the present invention, as shown in FIG. 2 and FIG. 3 , the medicine 1 can contain a liquid medicine or vaccine for the patient to take, or inject into the patient through the syringe 200 . The medicinal product 1 includes a bottle body 10 , a wafer set 20 , a lid 30 , an aluminum seal 40 , and a battery 50 . The bottle body 10 is used for containing liquid medicine or vaccine. The lid 30 covers the opening of the bottle body 10 , and the aluminum seal 40 seals the lid 30 on the bottle body 10 , so that the user can confirm whether the lid 30 has been unsealed. The battery 50 is provided on the bottle body 10 and supplies power to the wafer stack 20 .

In an embodiment of the present invention, as shown in FIG. 1 and FIG. 2 , the wafer set 20 is a flexible wafer, which is disposed on the bottle body 10 . The chip set 20 includes an identification tag 21 , a pharmaceutical blockchain module 22 , a positioning module 23 , an anti-counterfeiting module 24 and a temperature control module 25 . The identification tag 21 is a radio frequency identification (RFID) or a near field communication (NFC) tag. The identification label 21 includes a label information for storing a manufacturing history 211 , a circulation history 212 , a usage history 213 , an inventory history 214 and an insurance payment history 215 of the medicine 1 . The manufacturing process 211 is provided by the computer 600 of the pharmaceutical factory. The manufacturing process 211 includes the production and manufacturing information of the drug 1, such as the National Drug Code (NDC; National Drug Code), serial number, batch number, expiration date, ingredients, Information such as product transaction orders recorded in the supply chain. The distribution history 212 is provided by the logistics computer 700 . The circulation history 212 includes information such as the temperature control record, the whole process positioning record, the logistics vehicle number information, and the logistics personnel information of the medicine 1. The usage history 213 is provided by a medical computer 800 . The usage history 213 includes information on the injection terminal of the hospital patient, such as the name of the medical institution that used the drug 1 or the pharmacy that sold the drug 1, the doctor who injected the drug 1, the time when the drug 1 was administered, and the date of injection of the drug 1. Information of the patient, date of birth of the patient who injected the drug 1, vital signs of the patient who injected the drug 1 (such as blood pressure, heartbeat, respiration, body temperature, weight), past allergic reactions of the patient who injected the drug 1 , The past injection records of the patient who injected the drug 1, the family medical history of the patient who injected the drug 1, the current illness history and/or gene sequence of the patient who injected the drug 1, and the information of the medical personnel who provided the medical service. The inventory history 214 is provided by the warehouse computer 500 . The inventory history 214 includes a manufacturing date of the medicinal product 1 , a use period, a purchase date and an inventory quantity when the medicine 1 is purchased to the warehouse. The insurance payment process 215 is provided by the insurance payment computer 1000 . The insurance payment process 215 includes an insurance payment date and an insurance payment amount of the pharmaceutical product 1 .

The medicine block chain module 22 includes a computing chip and a wireless communication chip or a communication antenna, which is connected with the block chain network 300 signal, thereby the manufacturing process 211 , the circulation process 212 and the use process 213 of the medicine 1 are connected. , the inventory history 214 and the insurance payment history 215 are recorded in the blockchain network 300. With the traceability of the blockchain 300 and the characteristics that the records are not easily tampered, the manufacturing history 211 and the circulation history of the pharmaceutical product 1 are recorded and tracked. 212. Use process 213, inventory process 214 and insurance payment process 215. The positioning module 23 is a global positioning system (Global Positioning System) chip, and the positioning module 23 is used for positioning the medicine 1 to determine the current position of the medicine 1 and record the relationship between the delivery process and the time point in the whole process, so as to confirm the delivery time record of location and driving track. In this embodiment, the anti-counterfeiting module 24 is an anti-counterfeiting label for the user to confirm the reliability and safety of the medicine 1 . The temperature control module 25 is a chip with a temperature sensing function, and the temperature control module 25 is used to detect and monitor the temperature of the medicine 1, thereby monitoring whether the medicine 1 is at a suitable temperature to avoid the influence of overheating environment Pharmaceutical activity of medicinal product 1.

In addition, in addition to connecting to the blockchain network 300 through the pharmaceutical blockchain module 22 to record data, the pharmaceutical factory computer blockchain module 610 of the pharmaceutical factory computer 600 can also be connected to the blockchain The network 300 records the manufacturing process 211 ; the logistics computer blockchain module 710 of the logistics computer 700 can be connected to the blockchain network 300 to record the circulation process 212 ; the medical computer blockchain module 810 of the medical computer 800 can Connect to the blockchain network 300 to record the usage history 213 ; the warehouse computer blockchain module 510 of the warehouse computer 500 can be connected to the blockchain network 300 to record the inventory history 214 . The insurance payment blockchain module 1010 of the insurance payment computer 1000 can be connected to the blockchain network 300 to record the insurance payment process 215 .

In an embodiment of the present invention, as shown in FIG. 1 , the payment cash flow system 900 for tracking and managing pharmaceuticals includes a server 100 . The server 100 of the pharmaceutical tracking management payment cash flow system 900 can be connected to the blockchain network 300, the external computer 400, the pharmaceutical factory computer 600, the logistics computer 700, the medical computer 800, the storage computer 500 and the insurance cash flow payment computer 1000 String. The server 100 includes a blockchain module 110 , a message transmission/reception module 120 , a management module 130 and a database 140 . The blockchain module 110 includes a computing chip and a wireless communication chip or a communication antenna, the signal of which is connected to the blockchain network 300 to obtain the manufacturing process 211 and the distribution process of the medicine 1 recorded in the blockchain network 300 212. Use process 213, inventory process 214 and insurance payment process 215. The message transmission/reception module 120 is, for example, a network card, which is used to connect with the external computer 400 , the pharmaceutical factory computer 600 , the logistics computer 700 , the medical computer 800 , the warehouse computer 500 and the insurance payment computer 1000 for mutual transmission. information to receive the label information of the medicine 1 and the usage history of manufacturing and distribution, that is, the information transmission/reception module 120 respectively receives the manufacturing process 211 and the circulation of the medicine 1 sent by the manufacturer, the logistics provider, the user and the warehouse. Process 212, usage process 213, inventory process 214 and insurance payment process 215; the message transmission/reception module 120 also transmits the received manufacturing and distribution usage process, inventory process 214 and insurance payment process 215 to a block Link network 300 and database 140. The database 140 is connected to the blockchain module 110 , the message transmission/reception module 120 and the management module 130 by signals, and the database 140 is used for storing identification tags, manufacturing, distribution and use history, inventory history 214 and insurance payment history 215 .

The management module 130 is a central processing unit whose signal is connected to the blockchain module 110 and the message transmission/reception module 120 . The management module 130 includes a process query module 131 and an inventory and cash flow management module 132 . The history query module 131 is used to obtain the manufacturing and distribution usage history of the medicine 1 corresponding to the identification label from the database 140 according to the label information, and then transmit the manufacturing and distribution usage history to the message transmission/reception module 120 so as to transmit the information The receiving module 120 transmits the manufacturing and distribution usage history to the external computer 400 , the pharmaceutical factory computer 600 , the logistics computer 700 , the medical computer 800 and the warehouse computer 500 . The signal of the inventory and cash flow management module 132 is connected to the history query module 131. The inventory and cash flow management module 132 is used to obtain the inventory history 214 and the insurance cash flow of the medicine 1 corresponding to the identification label from the database 140 according to the label information. Payment process 215. The inventory and cash flow management module 132 is further configured to monitor whether the medicine 1 has expired according to the manufacturing date and the expiration date of the obtained inventory history 214 , and monitor the medicine 1 according to the manufacturing date, the expiration date and the stock quantity of the inventory history. Whether it should be returned or transferred.

In an embodiment of the present invention, the tag reader/writer 820 is a radio frequency identification (RFID) reader/writer or a Near Field Communication (NFC) tag reader/writer. The tag reader/writer 820 is connected to the server 100 by a signal, and the tag reader/writer 820 is used to read at least one of the manufacturing process 211 , the distribution process 212 , the usage process 213 , the inventory process 214 and the insurance payment process 215 in the identification tag 21 One; or the tag reader/writer 820 can be used to input the manufacturing process 211 , the distribution process 212 , the usage process 213 , the inventory process 214 and the insurance payment process 215 into the identification tag 21 , and use the pharmaceutical blockchain module 22 to enter the identification tag 21 . The manufacturing process 211 , the distribution process 212 , the use process 213 , the inventory process 214 and the insurance payment process 215 are recorded in the blockchain network 300 ; or the tag reader 820 can be obtained through the pharmaceutical blockchain module 22 . The manufacturing process 211 , the circulation process 212 , the use process 213 , the inventory process 214 and the insurance payment process 215 recorded on the blockchain network 300 and the identification tag 21 is entered. According to a specific embodiment of the present invention, the tag reader/writer 820 can be directly installed in a pharmaceutical factory that manufactures the medicine 1 , a logistics institution that transports the medicine 1 , or a medical institution that uses or sells the medicine 1 and trace-link The management server is used as the tracking data of the global drug supply chain; the user can scan the identification tag 21 with the tag reader 820 to obtain the tag information, so that the medical staff can know the manufacturing, distribution, use history and inventory of the drug 1 Process 214 and Insurance Payment Process 215 to ensure patient medication safety.

When the pharmaceutical factory is making the medicine 1, the staff of the pharmaceutical factory can put the liquid medicine or vaccine into the bottle body 10, cover the bottle body 10 with the lid 30 and cover the aluminum seal 40 to seal the lid 30 on the bottle body 10 . Then, the staff of the pharmaceutical factory can use the signal of the pharmaceutical factory computer 600 to connect to the tag reader/writer 820, input the manufacturing process 211 of the drug 1 into the identification tag 21, and use the drug blockchain module 22 to record the manufacturing process 211. It is recorded in the blockchain network 300, and the manufacturing process 211 is transmitted to the medicine tracking management payment cash flow system 900 through the network. After the preparation of the medicine 1 is completed, the staff of the logistics organization can transport the medicine 1 from the pharmaceutical factory to the medical institution, and when the staff of the logistics institution is in the process of transporting the medicine 1, the staff of the logistics organization can use the The signal of the logistics computer 700 is connected to the label reader/writer 820, the circulation history 212 of the medicine 1 is input into the identification label 21, and the circulation history 212 is recorded in the blockchain network 300 through the medicine blockchain module 22, and through The network transmits the circulation history 212 to the pharmaceutical tracking management payment cash flow system 900 . After the medicine 1 is delivered to the medical institution, the staff of the medical institution can use the signal of the medical computer 800 to connect to the tag reader/writer 820, input the usage history 213 of the medicine 1 into the identification tag 21, and pass the medicine block chain The module 22 records the usage history 213 in the blockchain network 300, and transmits the usage history 213 to the medicine tracking management payment cash flow system 900 through the network. If the medicine 1 is not used and is stored in the refrigerated warehouse of the hospital or pharmacy, the staff at the warehouse can use the signal of the storage computer 500 to connect to the tag reader/writer 820 to record the inventory history 214 of the medicine 1 in the blockchain. The network 300, and the inventory history 214 is transmitted to the pharmaceutical tracking management payment cash flow system 900 through the network. In addition, when the medicine 1 is sold to hospitals, pharmacies or patients, and there is a payment behavior such as insurance or cash flow, the staff at the insurance cash flow payment terminal can use the signal of the insurance cash flow payment computer 1000 to connect to the label reader 820. The insurance payment process 215 of the medicine 1 is recorded in the blockchain network 300, and the insurance payment process 215 is transmitted to the medicine tracking management payment cash flow system 900 through the network. In this way, both the blockchain network 300 and the identification tag 21 will completely record the manufacturing process 211 , the circulation process 212 , the use process 213 , the inventory process 214 and the insurance payment process 215 of the medicine 1 . In addition, after the information transmission/reception module 120 of the pharmaceutical tracking management payment cash flow system 900 receives the manufacturing history 211 , the circulation history 212 , the usage history 213 , the inventory history 214 and the insurance cash flow payment history 215 , it sends the manufacturing history 211 , circulation history 212 , usage history 213 , inventory history 214 and insurance payment history 215 are transmitted to the database 140 , so the drug tracking management payment flow system 900 will also completely record the manufacturing history 211 and circulation history 212 of the drug 1 , use process 213, inventory process 214 and insurance payment process 215.

If the patient using the drug 1 has allergies or other adverse reactions, the staff or patients of the medical institution can use the external computer 500 to connect to the drug tracking and management payment cash flow system 900, and the tag reader 820 can read it. The label information of the identification label 21 of the medicine 1 is obtained, and the label information is transmitted to the medicine tracking and management payment cash flow system 900, so as to know whether there is an error in the manufacturing, distribution, use and inventory of the medicine 1. When the information transmission/reception module 120 receives the label information from the external computer 500, the history query module 131 of the management module 130 obtains the manufacturing and distribution of the medicine 1 corresponding to the identification label from the database 140 according to the content of the label information The usage history, and the inventory and cash flow management module 132 also obtains the inventory history 214 and the insurance cash flow payment history 215 of the medicine 1 corresponding to the identification label from the database 140 according to the label information. The message transmission/reception module 120 transmits the manufacturing, distribution and usage history, the inventory history 214 and the insurance payment flow history 215 to the external computer 500, so that the staff and patients who operate the external computer 500 can view the returned information by viewing the information. Manufacturing, circulation and use history, inventory history 214 and insurance payment history 215, and knowing the manufacturing history 211, circulation history 212, use history 213, inventory history 214, and insurance payment history 215 of drug 1, and then can understand the responsibility In pharmaceutical factories, logistics organizations, medical institutions or warehousing institutions, clarify the responsibility of medical disputes and drug relief, and understand the detailed items of insurance and cash flow.

In addition, the inventory and cash flow management module 132 can also monitor whether the medicine 1 has expired according to the manufacturing date and expiration date of the obtained inventory history 214 , and monitor the medicinal product according to the manufacturing date, expiration date and inventory quantity of the inventory history. 1 Whether it should be returned or transferred. If the inventory and cash flow management module 132 confirms that the inventory quantity of the medicine 1 is insufficient, the inventory and cash flow management module 132 can issue a warning to the external computer 400 or the storage computer 500 to notify the staff that the medicine needs to be checked from other storage terminals. The inventory and cash flow management module 132 determines that the inventory of the pharmaceutical product 1 is sufficient but is about to expire, the inventory and cash flow management module 132 can The information transmission/reception module 120 is connected to the warehouse computers of other warehouses to confirm whether there are other warehouses currently out of stock and urgently in need of the medicine 1. In this way, the inventory and cash flow management module 132 can issue a warning To the external computer 400 or the warehouse computer 500, to notify the staff to transfer the soon-to-expire pharmaceutical 1 to other warehouses that are out of stock, so as to avoid waste of the pharmaceutical 1, or to return the soon-to-expire pharmaceutical 1 to the pharmacy for Avoid wasted costs.

However, the methods of obtaining the manufacturing history 211 , the distribution history 212 , the usage history 213 , the inventory history 214 and the insurance payment history 215 by the staff of each institution are not limited to the above-mentioned methods. For example, the staff of each institution can also operate the pharmaceutical factory separately. Computer 600, logistics computer 700, medical computer 800, warehouse computer 500 or insurance cash flow payment computer 1000 to connect to the drug tracking management payment cash flow system 900 and get a response message; or the staff can also use the tag reader 820 reads the manufacturing history 211 , the distribution history 212 , the usage history 213 , the inventory history 214 and the insurance payment history 215 stored in the identification tag 21 .

With the new drug tracking management payment cash flow system 900, it is possible to manage and track the manufacturing process, storage and delivery process, usage process and insurance cash flow payment process of pharmaceuticals, so as to enhance the medication safety of patients and medical institutions. This new type of medicines 1 and medicines tracking management payment cash flow system 900 can meet the minimum sales package of prescription prescriptions, which can improve the efficiency of the supply chain, eliminate illegal counterfeit medicines, improve the procedures and efficiency of the recall of prescription medicines, clarify medical disputes, medicines Responsibility for Relief Attribution. In addition, the new drug tracking management payment cash flow system 900 can collect the medical record information of injection patients who use the new drug 1 around the world, as a big data database of drug vaccine injections, and provide information on the correlation between vaccines/drugs and gene sequences. Compare, upload the database to the blockchain network, pharmaceutical factory institutions (manufacturing side), logistics institutions (logistics side), medical institutions (physician side), warehousing institutions (warehousing side), insurance companies (insurance cash flow payment) The storage and analysis of the third party's fair and remote backup data terminal, as well as the personal storage of patients' personal injections and electronic medical records, are in line with the spirit of blockchain electronic medical records.

It should be noted that the above are only examples, but are not limited to examples. For example, those that do not deviate from the basic structure of the present invention shall be within the scope of the rights claimed by this patent, and shall be subject to the scope of the patent application.

1: Pharmaceuticals 10: bottle body 20: Chipset 21: Identifying tags 211: Manufacturing History 212: Circulation History 213: Usage History 214: Inventory History 215: Insurance payment process 22: Pharmaceutical blockchain module 23: Positioning module 24: Anti-counterfeiting module 25: Temperature control module 30: Cover 40: Aluminum seal 50: battery 100: Server 110: Blockchain Module 120: Message transmission/reception module 130: Query message processor 131: History query module 132: Inventory and cash flow management module 140:Database 200: Syringe 300: Blockchain Network 400: External computer 500: Warehouse Computer 510: Warehousing computer blockchain module 600: Pharmaceutical factory computer 610: Pharmaceutical factory computer blockchain module 700: Logistics Computer 710: Logistics Computer Blockchain Module 800: Medical Computer 810: Medical Computer Blockchain Module 820: Tag read and write 900: Pharmaceutical tracking management payment cash flow system 1000: Insurance cash flow to pay computer 1010: Insurance flow payment blockchain module

Figure 1 is a system architecture diagram of a pharmaceutical tracking management payment cash flow system, a blockchain network, an external computer, a pharmaceutical factory computer, a logistics computer, a medical computer, a storage computer and an insurance cash flow payment computer according to an embodiment of the present invention . FIG. 2 is an exploded perspective view of a pharmaceutical product according to an embodiment of the present invention. FIG. 3 is a schematic diagram of a medicine and a syringe according to an embodiment of the present invention.

1: Pharmaceuticals

20: Chipset

21: Identifying tags

211: Manufacturing History

212: Circulation History

213: Usage History

214: Inventory History

215: Insurance payment process

22: Pharmaceutical blockchain module

23: Positioning module

24: Anti-counterfeiting module

25: Temperature control module

50: battery

100: Server

110: Blockchain Module

120: Message transmission/reception module

130: Query message processor

131: History query module

132: Inventory and cash flow management module

140:Database

300: Blockchain Network

400: External computer

500: Warehouse Computer

510: Warehousing computer blockchain module

600: Pharmaceutical factory computer

610: Pharmaceutical factory computer blockchain module

700: Logistics Computer

710: Logistics Computer Blockchain Module

800: Medical Computer

810: Medical Computer Blockchain Module

820: Tag Reader

900: Pharmaceutical tracking management payment cash flow system

1000: Insurance cash flow to pay computer

1010: Insurance flow payment blockchain module

Claims (9)

A pharmaceutical tracking management payment cash flow system is used to receive a manufacturing, distribution and use history, an inventory history and an insurance cash flow payment history of a pharmaceutical transmitted by a third-party organization, and allows a user to track the manufacturing and distribution process. The usage history, the inventory history and the insurance cash flow payment history, wherein the medicine includes an identification label and the identification label includes a label information, and the medicine tracking management payment flow system includes: a database; a message transmission/reception module for receiving the label information, the manufacturing and distribution history, the inventory history, and the insurance payment history of the pharmaceutical product, and transmits the manufacturing and distribution history, the inventory history, and the insurance The cash flow payment process is transmitted to a blockchain network and the database; and a management module, the signal is connected to the message transmission/reception module and the database, the management module includes a process query module and an inventory and cash flow management module, the process query module is based on the tag information from the The database obtains the manufacturing and distribution usage history of the pharmaceutical product corresponding to the identification label, the inventory and cash flow management module signal is connected to the process query module, and the inventory and cash flow management module obtains the data from the data according to the label information The library obtains the inventory history and the insurance payment history of the medicine corresponding to the identification label. The pharmaceutical tracking management payment cash flow system according to claim 1, wherein the third-party organization includes a manufacturer, a logistics provider, a user terminal, a storage terminal and an insurance cash flow payment terminal of the pharmaceutical product, The manufacturing, distribution and use history includes a manufacturing history, a circulation history, and a use history; the message transmission/reception module receives the manufacturing history, the circulation history, and the use history transmitted by the manufacturer, the logistics provider, and the user respectively. process, and receive the inventory process sent by the warehouse terminal, and receive the insurance cash flow payment process sent by the insurance cash flow payment terminal. The pharmaceutical tracking management payment cash flow system according to claim 2, wherein the inventory history includes a manufacturing date, a use period, a purchase date, an inventory quantity, a shipment date and a use date of the pharmaceutical, The insurance payment process includes an insurance payment date and an insurance payment amount of the pharmaceutical product. The pharmaceutical tracking management payment cash flow system according to claim 3, wherein the inventory and cash flow management module is further configured to monitor whether the pharmaceutical is expired according to the inventory history. The pharmaceutical tracking management payment cash flow system according to claim 4, wherein the inventory and cash flow management module is further configured to determine whether the pharmaceutical should be returned or transferred according to the inventory history. The payment cash flow system for tracking and managing pharmaceuticals according to claim 5, wherein the user includes a tag reader/writer, and the user obtains the tag information through the tag reader/writer. The pharmaceutical tracking management payment cash flow system as claimed in claim 6, wherein the identification tag is a radio frequency tag or a short-range wireless communication tag, and the tag reader is a radio frequency identification (RFID) reader or A Near Field Communication (NFC) tag reader/writer. The payment cash flow system for tracking and managing pharmaceuticals according to claim 7, wherein the pharmaceuticals include pharmaceutical injections. The pharmaceutical tracking management payment cash flow system as claimed in claim 8, wherein the user terminal is a medical institution, and the use process is hospital patient injection terminal information.

Images